MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, KALV has $335,375K in assets. $338,086K in debts. $229,342K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
558.18%
Quick Ratio
552.21%
Cash Ratio
399.86%
Debt to Asset Ratio
100.81%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Right of use assets
    • Research and development tax cre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Royalty obligation - net of curr...
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
229,342
Marketable securities
70,872
Accounts receivable, net
2,593
Inventory
3,428
Research and development tax credit receivable
6,200
Prepaid expenses and other current assets
7,712
Total current assets
320,147
Property and equipment, net
3,034
Right of use assets
9,825
Other assets
2,369
Total assets
335,375
Accounts payable
8,268
Accrued expenses and other current liabilities
33,897
Lease liability - current portion
1,621
Royalty obligation - current portion
13,569
Total current liabilities
57,355
Deferred revenue - net of current portion
11,714
Lease liability - net of current portion
10,727
Royalty obligation - net of current portion
119,063
Convertible notes
139,227
Total liabilities
338,086
Common stock, 0.001 par value 100,000,000 shares authorized at december 31, 2025, april 30, 2025 and april 30, 2024 50,900,777, 49,762,048 and 42,521,975 shares issued and outstanding at december 31, 2025, april 30, 2025 and april 30, 2024, respectively
51
Additional paid-in capital
767,061
Accumulated deficit
-762,694
Accumulated other comprehensive loss
-7,129
Total stockholders' (deficit) equity
-2,711
Total liabilities and stockholders' (deficit) equity
335,375
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$229,342K Marketable securities$70,872K Prepaid expenses andother current assets$7,712K Research and developmenttax credit...$6,200K Inventory$3,428K Accounts receivable, net$2,593K Total current assets$320,147K Right of use assets$9,825K Property and equipment,net$3,034K Other assets$2,369K Total assets$335,375K Accumulated deficit-$762,694K Accumulated othercomprehensive loss-$7,129K Total liabilities andstockholders' (deficit)...$335,375K Total stockholders'(deficit) equity-$2,711K Additional paid-in capital$767,061K Common stock, 0.001 parvalue 100,000,000...$51K Total liabilities$338,086K Convertible notes$139,227K Royalty obligation - netof current portion$119,063K Total currentliabilities$57,355K Deferred revenue - net ofcurrent portion$11,714K Lease liability - netof current portion$10,727K Accrued expenses andother current...$33,897K Royalty obligation -current portion$13,569K Accounts payable$8,268K Lease liability -current portion$1,621K

KalVista Pharmaceuticals, Inc. (KALV)

KalVista Pharmaceuticals, Inc. (KALV)